No Prescription |
 |
 | ||
|
PARIET Aciphex |
|
| ||
No Prescription » Prescription Drugs 13 » PARIET Aciphex Rabeprazole is used to treat conditions where the stomach produces too much acid including ulcers gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome. Rabeprazole is used in combination with other medications to eliminate H. pylori a bacteria that causes ulcers. Rabeprazole is in a class of medications called proton-pump inhibitors. It works by decreasing the amount of acid made in the stomach.Rabeprazole comes as a delayed-release (long-acting) tablet to take by mouth. It is usually taken once a day for 4 to 8 weeks but it is sometimes taken for a longer time. When taken for ulcers rabeprazole should be taken after the morning meal. When taken in combination with other medications to eliminate H. pylori rabeprazole is taken twice a day with the morning and evening meals for 7 days. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take rabeprazole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Swallow the tablets whole; do not split chew or crush them. Buy PARIET Aciphex and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About PARIET Aciphex: Product Type: Prescription Drugs 13 PARIET ( Aciphex Generic Rabeprazole ) PARIET (Aciphex Generic Rabeprazole) Aciphex Generic Rabeprazole 10mg Tabs Aciphex Generic Rabeprazole PARIET
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
